CYMABAY THERAPEUTICS INC (CBAY) Stock Analyst Earnings Estimates
NASDAQ:CBAY - Nasdaq - US23257D1037 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.073M | 11.961M -61.51% | 116.93M 877.59% | 252.7M 116.11% | 500.89M 98.22% | 735.79M 46.90% | 1.021B 38.76% | 1.159B 13.52% | |||
| EBITDA YoY % growth | -86.89M -64.94% | -92.4M -6.34% | -100.998M -9.31% | -167.754M -66.10% | -89.332M 46.75% | 82.11M 191.92% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -87.58M -64.28% | -93.11M -6.31% | -101.679M -9.20% | -173.058M -70.20% | -111.906M 35.34% | 6.898M 106.16% | 209.55M 2,937.84% | 408.44M 94.91% | 703.7M 72.29% | 810.98M 15.25% | |
| Operating Margin | N/A | N/A | -327.23% | -1,446.85% | -95.70% | 2.73% | 41.84% | 55.51% | 68.92% | 69.97% | |
| EPS YoY % growth | -1.26 -68.00% | -1.21 3.97% | -0.97 19.83% | -1.46 -50.27% | -1.06 27.14% | -0.31 70.86% | 1.13 463.96% | 2.38 111.59% | 4.50 88.78% | 4.83 7.41% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 -10.21% | -0.35 -3,419.00% | -0.43 -33.48% | -0.43 -23.13% | -0.83 -158.51% | -0.65 -85.51% | -0.61 -43.28% | -0.79 -82.25% | -0.43 48.15% | -0.20 68.75% | -0.02 96.67% |
| Revenue Q2Q % growth | -100.00% | 852.863K | 7.753M 13,501.75% | 7.646M | 7.646M | 15.788M 1,751.18% | 28.858M 272.22% | 39.817M 420.76% | 70.254M 818.83% | 94.223M 496.80% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -37.509M -39.54% | -41.743M -41,642.65% | -50.223M -55.92% | -51.796M -21.88% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.35 -16.67% | -0.32 | -0.03 | -11.02% |
| Q3 2023 Q2Q % growth | -0.32 -14.29% | -0.30 | -0.02 | -7.02% |
| Q2 2023 Q2Q % growth | -0.01 96.77% | -0.21 | 0.20 | 95.16% |
| Q1 2023 Q2Q % growth | -0.29 9.38% | -0.09 | -0.20 | -223.89% |
| Q4 2022 Q2Q % growth | -0.30 11.76% | -0.31 | 0.01 | 1.96% |
| Q3 2022 Q2Q % growth | -0.28 15.15% | -0.31 | 0.03 | 8.83% |
| Q2 2022 Q2Q % growth | -0.31 8.82% | -0.30 | -0.01 | -1.73% |
| Q1 2022 Q2Q % growth | -0.32 -28.00% | -0.32 | 0.00 | -1.28% |
| Q4 2021 Q2Q % growth | -0.34 -47.83% | -0.27 | -0.07 | -27.59% |
| Q3 2021 Q2Q % growth | -0.33 -94.12% | -0.27 | -0.06 | -22.96% |
| Q2 2021 Q2Q % growth | -0.34 -112.50% | -0.27 | -0.07 | -24.48% |
| Q1 2021 Q2Q % growth | -0.25 -31.58% | -0.25 | 0.00 | -0.35% |
| Q4 2020 Q2Q % growth | -0.23 34.29% | -0.20 | -0.03 | -12.67% |
| Q3 2020 Q2Q % growth | -0.17 55.26% | -0.17 | 0.00 | -0.40% |
| Q2 2020 Q2Q % growth | -0.16 54.29% | -0.24 | 0.08 | 34.37% |
| Q1 2020 Q2Q % growth | -0.19 48.65% | -0.31 | 0.12 | 37.73% |
| Q4 2019 Q2Q % growth | -0.35 | -0.40 | 0.05 | 11.76% |
| Q3 2019 Q2Q % growth | -0.38 | -0.38 | 0.00 | -1.10% |
| Q2 2019 Q2Q % growth | -0.35 | -0.37 | 0.02 | 6.35% |
| Q1 2019 Q2Q % growth | -0.37 | -0.34 | -0.03 | -7.39% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 57K | 45.329K | 11.671K | 25.75% |
| Q3 2023 Q2Q % growth | 435.815K | -435.815K | -100.00% | |
| Q2 2023 Q2Q % growth | 31.02M | 10.096M | 20.924M | 207.25% |
| Q1 2023 Q2Q % growth | 21.777M | -21.777M | -100.00% | |
| Q4 2021 Q2Q % growth | 6.557M | -6.557M | -100.00% | |
| Q3 2021 Q2Q % growth | 6.375M | -6.375M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.71% | -0.67% | -4.69% | -5.59% |
| Revenue | -100% | N/A | -33.96% | -25.58% |